Brief: Sprint Bioscience Q4 operating result swings to profit of SEK 2.7 mln
Feb 22 (Reuters) - Sprint Bioscience AB SPRINT.ST
* Q4 revenue 13.0 million Swedish crowns ($1.5 million) versus 5.8 million crowns year ago
* Q4 operating profit 2.7 million crowns versus loss 4.0 million crowns year ago
Source text for Eikon: ID:nWkr3GwpsD
Further company coverage: SPRINT.ST
($1 = 8.9897 Swedish crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program